The use of sputum eosinophils in the evaluation of occupational asthma

Current Opinion in Allergy and Clinical Immunology

Volumn 4, Issue 2, 2004, Pages 81-85

  Lemière, Catherine ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Airway hyperresponsiveness; Eosinophils; Induced sputum; Occupational asthma

Indexed keywords

METHACHOLINE;

BRONCHUS HYPERREACTIVITY; CELL COUNT; DISEASE SEVERITY; EOSINOPHIL; HUMAN; LABORATORY TEST; MONITOR; NEUTROPHIL; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; REVIEW; SENSITIZATION; SPUTUM ANALYSIS; WORKPLACE;

EID: 2342581534     PISSN: 15284050     EISSN: None     Source Type: Journal    
DOI: 10.1097/00130832-200404000-00002     Document Type: Review

References (34)

1. Malo J, Ghezzo H, L'Archevêque J, et al. Is the clinical history a satisfactory means of diagnosing occupational asthma? Am Rev Respir Dis 1991; 143:528-532.
2. Tarlo SM, Boulet LP, Cockcroft DW, et al. Directives de la Société Canadienne de Thoracologie pour l'asthme professionnel [Canadian Thoracic Society guidelines for occupational asthma]. Can Respir J 1998; 5:397-410.
3. Perrin B, Lagier F, L'Archevêque J, et al. Occupational asthma: validity of monitoring of peak expiratory flow rates and non-allergic bronchial responsiveness as compared to specific inhalation challenge. Eur Respir J 1992; 5:40-48.
4. 20 and peak expiratory flow rate in cedar asthma. J Allergy Clin Immunol 1990; 85:592-598.
5. Moscato G, Godnic-Cvar J, Maestrelli P, et al. Statement on self-monitoring of peak expiratory flows in the investigation of occupational asthma. J Allergy Clin Immunol 1995; 96:295-301.
6. Chan-Yeung M, Malo JL, Tarlo SM, et al. Proceedings of the first Jack Pepys Occupational Asthma Symposium. Am J Respir Crit Care Med 2003; 167:450-471.
7. Pizzichini E, Pizzichini M, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154:308-317.
8. Lemiere C, Taha R, Olivenstein R, Hamid O. Comparison of cellular composition of induced sputum analyzed with Wright staining and immunocytochemistry. J Allergy Clin Immunol 2001; 108:521-523.
9. Lemiere C, Chaboilliez S, Trudeau C, et al. Characterization of airway inflammation after repeated exposures to occupational agents. J Allergy Clin Immunol 2000; 106:1163-1170.
10. Pin I, Freitag A, O'Byrne P, et al. Changes in the cellular profile of induced plutum after allergen-induced asthmatic responses. Am Rev Respir Dis 1992; 145:1265-1269.
11. Fahy J, Liu J, Wong H, Boushey H. Analysis of cellular and biochemical constituents of induced sputum after allergen challenge: a method for studying allergic airway inflammation. J Allergy Clin Immunol 1994; 93:1031-1039.
12. Wong B, Dolovich J, Ramsdale E, et al. Formoterol compared with beclomathasone and placebo on allergen-induced asthmatic responses. Am Rev Respir Dis 1992; 146:1156-1160.
13. Pizzichini M, Kidney J, Wong B, et al. Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses. Eur Respir J 1996; 9:449-455.
14. Gibson P, Wong B, Hepperle M, et al. A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid. Clin Exp Allergy 1992; 22:525-532.
15. Pizzichini MM, Pizzichini E, Clelland L, et al. Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment. Am J Respir Crit Care Med 1997; 155:1501-1508.
16. Hargreave FE. Induced sputum and response to glucocorticoids. J Allergy Clin Immunol 1998; 102 (Suppl):S102-S105.
17. Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ. Non-eosinophilic corticosteroid unresponsive asthma [Letter]. Lancet 1999; 353:2213-2214.
18. Godon P, Boulet LP, Malo JL, et al. Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids. Eur Respir J 2002; 20:1364-1369.
19. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360:1715-1721. This work shows how the use of induced sputum can improve the management of asthma, as shown by the reduction in asthma exacerbations in asthmatic subjects followed by sputum cell counts compared with asthmatic subjects followed according to the BTS asthma guidelines.
20. Romagnoli M, Vachier I, Tarodo DIF, et al. Eosinophilic inflammation in sputum of poorly controlled asthmatics. Eur Respir J 2002; 20:1370-1377.
21. Obata H, Dittrick M, Chan H, Chan-Yeung M. Sputum eosinophils and exhaled nitric oxide during late asthmatic reaction in patients with western red cedar asthma. Eur Respir J 1999; 13:489-495.
22. Lemiere C, Chaboillez S, Malo JL, Cartier A. Changes in sputum cell counts after exposure to occupational agents: what do they mean? J Allergy Clin Immunol 2001; 107:1063-1068.
23. Alvarez MJ, Estrada JL, Gozalo F, et al. Oilseed rape flour: another allergen causing occupational asthma among farmers. Allergy 2001; 56:185-188.
24. Maestrelli P, Calcagni P, Saetta M, et al. Sputum eosinophilia after asthmatic responses induced by isocyanates in sensitized subjects. Clin Exp Allergy 1994; 24:29-34.
25. Quirce S, Baeza ML, Tornero P, et al. Occupational asthma caused by exposure to cyanoacrylate. Allergy 2001; 56:446-449.
26. Park H, Jung K, Kim H, et al. Neutrophil activation following TDI bronchial challenges to the airway secretion from subjects with TDI-induced asthma. Clin Exp Allergy 1999; 29:1395-1401.
27. Lemiere C, Romeo P, Chaboillez S, et al. Airway inflammation and functional changes after exposure to different concentrations of isocyanates. J Allergy Clin Immunol 2002; 110:641-646. This paper shows the influence of the concentration and length of exposure to isocyanates on the asthmatic reaction and airway inflammation of subjects with isocyanate-induced asthma.
28. Leigh R, Hargreave FE. Occupational neutrophilic asthma. Can Respir J 1999; 1999; 6:194-196.
29. Park HS, Jung KS, Hwang SC, et al. Neutrophil infiltration and release of IL-8 in airway mucosa from subjects with grain dust-induced occupational asthma. Clin Exp Allergy 1998; 28:724-730.
30. Douwes J, Gibson P, Pekkanen J, Pearce N. Non-eosinophilic asthma: importance and possible mechanisms. Thorax 2002; 57:643-648. This is a literature review that shows that only 50% of cases of asthma are characterized by an eosinophilic type of inflammation. The implications of this observation are discussed.
31. Lemiere C, Pizzichini MM, Balkissoon R, et al. Diagnosing occupational asthma: use of induced sputum [see Comments]. Eur Respir J 1999; 13:482-488.
32. Anees W, Huggins V, Pavord ID, et al. Occupational asthma due to low molecular weight agents: eosinophilic and non-eosinophilic variants. Thorax 2002; 57:231-236.
33. Chan-Yeung M, Obata H, Dittrick M, et al. Airway inflammation, exhaled nitric oxide, and severity of asthma in patients with western red cedar asthma. Am J Respir Crit Care Med 1999; 159:1434-1438.
34. Maghni K, Lemiere C, Ghezzo H, et al. Airway inflammation after cessation of exposure to agents causing occupational asthma. Am J Respir Crit Care Med 2004; 169:367-372. This paper describes the characteristics of airway inflammation observed in workers with occupational asthma due to various agents years after removal from exposure and their correlation with the persistence of airway responsiveness.